Personal tools
Document Actions

2003/1MC - Abstract

Grant Information

Diabetes - Start-Up
The Role of Uncoupling Proteins in Glucose-stimulated Insulin Secretion in Diabetes
Leena Haataja, PhD
Larry L. Hillblom Islet Research Center
Funding Status
  • Completed
  • 3 years, $60,000 per year
  • 7/1/2003 to 6/30/2006


2003/1MC - Abstract
Brief Summary
"The Role of Uncoupling Proteins in Glucose-stimulated Insulin Secretion in Diabetes"

UCP-2 and UCP-3 Proteins are Differentially Regulated in Pancreatic Beta-cells:
Increased uncoupling protein-2 (UCP-2) expression has been associated with impaired insulin secretion, whereas UCP-3 protein levels are decreased in the skeleton muscle of type-2 diabetic subjects. We hypothesized an opposing effect of glucose on the regulation of UCP-2 and UCP-3 in pancreatic islets. We generated dominant negative UCP-2 adenovirus and measured insulin release from transduced human islets using perifusion. We studied UCP-2 and UCP-3 mRNA and protein levels in human islets cultured in the presence of different glucose concentrations and analyzed UCP3 expression in human pancreatic sections using immunohistochemistry. Dominant negative UCP-2 expression in human islets increased insulin secretion compared to control islets (p<0.05). UCP-3 mRNA is expressed in human islets, but the relative abundance of UCP-2 mRNA is 8-fold higher (p<0.05). Immunohistochemical analysis confirmed co-localization of UCP-3 protein with mitochondria in human beta-cells. UCP-2 protein expression in human islets was increased ~2-fold after high glucose exposure, whereas UCP-3 protein expression was decreased by ~40% (p<0.05).

These results suggest that UCP-2 and UCP-3 may have distinct roles in regulating beta-cell function. Increased expression of UCP-2 and decreased expression of UCP-3 in humans with chronic hyperglycemia may contribute to impaired glucose-stimulated insulin secretion. These data imply that mechanisms that suppress UCP-2 or mechanisms that increase UCP-3 expression and/or function are potential therapeutic targets to offset defects of insulin secretion in humans with type-2 diabetes.

online help

You are currently browsing the grant area of the website, where you have access to abstracts from research projects funded by LLHF.

The Funded Research area has a complete list of active and completed grants.


Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: